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Abstract.  Plantar epidermis of the bovine heel pad as 
well as human plantar and palmar epidermis contain 
large amounts of an acidic (type I) keratin polypeptide 
(No.  9) of Mr 64,000 which so far has not been found 
in epidermis of other sites of the body. We present 
evidence for the keratinous nature of this protein,  in- 
eluding its ability to form cytokeratin complexes and 
intermediate-sized  filaments in vitro.  We have isolated 
RNA from plantar epidermis of both species and 
show,  using translation  in vitro,  that these polypeptides 
are genuine products of distinct mRNAs.  Using im- 
munofluorescence microscopy with specific antibodies 
against this protein,  we demonstrate its location in 
most cells of suprabasal layers of plantar epidermis as 
well as in sparse keratinocytes which occur, individu- 
ally or in small clusters,  in upper layers of epidermis 
of other body locations.  We conclude that cytokeratin 
No.  9 is characteristic  of a  special program of ker- 
atinocyte differentiation which during morphogenesis 
is expressed in most epidermal keratinocytes of soles 
and palms but only in a few keratinocytes at other 
body sites. This example of cell type-specific expres- 
sion of a member of a multigene family in relation to 
a body site-related program of tissue differentiation 
raises important biological questions concerning the 
regulation of keratinocyte differentiation and morpho- 
genesis as well as the function of such topological het- 
erogeneity within a given type of tissue. 
C 
~LL type-specific expression of a certain protein of a 
multigene family is a widespread phenomenon in cell 
differentiation.  A particularly impressive  example is 
found in the large family of cytoskeletal-karyoskeletal pro- 
teins that includes the proteins forming the intermediate-sized 
filaments  (IFs) 1 of the cytoplasm (23, 40,  64,  71) and the 
proteins that  constitute  the nuclear lamina (6, 44).  The IF 
proteins are usually classified  according to their expression 
in certain pathways of cell differentiation:  cytokeratins occur 
in all epithelia,  neurofilaments  in neurons and in some other 
neurosecretory cells, glial filament protein in astrocytes and 
certain non-glial cells, desmin in myogenic cells, and vimen- 
tin in mesenchymally derived cells as well as in various other 
kinds of cells in which it can co-exist with any of the other 
kinds of IF proteins (for reviews see 23, 40, 53, 71). 
The cytokeratins display a further refined principle of cell 
type-specific expression, in that the IFs of different epithelia 
are formed by different sets of cytokeratin  polypeptides (13, 
19-21, 23, 72, 75).  For example,  in human tissues and tu- 
mors, 19 different cytokeratin polypeptides have been distin- 
guished  which  are  expressed  in  sets  characteristic  of a 
1.  Abbreviation  used in  this paper:  IF,  intermediate filament. 
specific type of epithelium  (9, 23, 45, 48, 55, 67, 68), and 
similar complexities of  cytokeratin polypeptide expression in 
different epithelia  have been reported for bovine and rodent 
tissues (9,  19-21, 23, 57).  The epithelial  cytokeratins,  like 
sheep wool keratins  (10), can be grouped into two subfami- 
lies, the usually somewhat smaller  acidic (type I) cytokera- 
tins and the mostly larger, more basic (type II) polypeptides 
(30, 33, 57, 64). 
Unlike the other types of IF proteins,  the cytokeratins  al- 
ways appear to be expressed as "pairs" of polypeptides; i.e., 
one representative  from both the basic and the acidic sub- 
family. These pairs  form four-chain  heterotypic complexes 
which represent the architectural  subunits of cytokeratin IFs 
in which the polypeptides of the two subfamilies are held to- 
gether by hydrogen bonds of varying strengths depending  on 
the pair in question (24, 54, 74). It has been emphasized  by 
some authors (9, 64, 67) that within each pair the basic (type 
II) partner exceeds the acidic (type I) partner by Mr ,~8,000. 
Certain cells contain  only one type of cytokeratin  pair (20, 
23, 25, 45, 54, 55) whereas others possess more, with up to 
11 different cytokeratin polypeptides existing in a single cell 
(25, 45, 46). While in vitro re-assembly experiments  show 
that most, probably all, cytokeratin polypeptides are able to 
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random  expression  and  pairing  has  not been observed in 
vivo. 
Biochemical analyses of IF proteins from a wide range of 
human tissues and tumors and immunolocalization  studies 
using  antibodies  specific  for  individual  cytokeratins  have 
shown that certain cytokeratins are typical of simple epithelia 
whereas others occur in stratified epithelia (1, 9,  12, 23, 25, 
45, 50, 70). Among the various stratified epithelia, epidermis 
contains a particularly rich complement of cytokeratin poly- 
peptides (3, 4, 7,  15, 20, 23, 27-29, 34, 45, 46, 49, 65-67), 
and fetal epidermis can be even more complex than neonatal 
and adult epidermis (5,  11, 47, 50, 58). Moreover, the differ- 
ent epithelia present in skin, such as hair follicles and their 
root sheaths, sweat glands, and sebaceous glands differ qual- 
itatively in their cytokeratin composition from the keratino- 
cytes of the interfollicular epidermis (46), despite their com- 
mon  embryological  origin  from  epidermis.  Furthermore, 
different  sets  of cytokeratins  are  synthesized  in  different 
epidermal layers, indicating the existence of a vertical pro- 
gram of changes of cytokeratin expression during keratino- 
cyte differentiation and maturation (3, 4, 27-29, 32, 47, 60, 
62, 73). 
In  addition  to  these  vertical  differences,  differences  of 
cytokeratin composition between epidermal tissue samples 
taken from different body sites have been reported, in partic- 
ular the specific occurrence,  in cow and human,  of an un- 
usually large (Mr 63,000-64,000),  acidic (type I) cytokera- 
tin  which  has  been  found  only  in  human  callus-forming 
epidermis (51) such as in foot soles or palms (45, 46, 49, 50; 
see also 7, 28, 32, 65) and in the corresponding bovine tissue 
(for anatomy,  see reference 76);  i.e.,  the heel pad on the 
posterior side of the hoof (el.  14,  17, 41, 63, 69). However, 
apparently because of the unusual properties of this polypep- 
tide and in view of various reports describing the formation 
of several epidermal keratins from precursor molecules by 
proteolytic and other modifications (8, 27, 28, 32), the sig- 
nificance of this sole- and palm-specific epidermal cytokera- 
tin polypeptide, which has been designated "cytokeratin No. 
9" (45, 57), has been questioned. In particular,  Sun and col- 
leagues (9, 66, 67) have expressed doubts as to whether this 
component represents an "intact,  genuine keratin  species" 
Therefore, we have examined this question in greater detail. 
Our present study provides evidence that cytokeratin No. 9 
is a  true cytokeratin encoded by a discrete mRNA that  is 
abundantly  expressed in the palmar and plantar  epidermis 
but can also occur,  in sparser cells,  in epidermis  of other 
body locations. 
Materials and Methods 
Preparation of  Cytoskeletal Material and Keratins 
for Gel Electrophoresis 
Epidermal tissue from bovine heel pads, muzzle epidermis, and body skin 
from various sites (14, 17, 20, 56) was obtained from cows, calves, and late 
fetuses by sectioning with a scalpel parallel to the surface. Tissue sections 
were either used directly or frozen in liquid nitrogen and stored at -80°C. 
Cytoskeletal material enriched in keratins was prepared by combinations of 
treatments with low and high salt buffers as well as Triton X-100 as described 
(2,  14,  17, 20). Alternatively, for extraction of cytokeratins the tissue sec- 
tions were thawed and resuspended in cold (4°C) 0.1 M citric acid-sodium 
citrate buffer (pH 2.3;  113 ml per g of wet weight tissue) as introduced by 
Skerrow and Matoltsy (61) and were homogenized for 2-3 min with a Poly- 
tron homogenizer (Kinematica Ltd., Lucerne, Switzerland) at 4°C. After 
filtration through four layers of gauze,  the material  was centrifuged at 
12,000 g for 15 min at 4"C. The supernatant was adjusted to pH 5.5 with 
NaOH, and the precipitating cytokeratins were collected by centrifugation 
for 10 min at 10,000 g and 4°C. The pellet obtained was washed twice with 
phosphate-buffered saline (PBS) and cytokeratin was solubilized in 9.5 M 
urea. Epidermal samples from other hair follicle-containing regions of the 
head and the back were taken in a similar fashion. 
Human foot-sole epidermis was obtained from human patients suffering 
from obstructive vascular disease (stages III and IV) who had to undergo 
amputation. Skin areas not affected by tissue necrosis were dissected from 
the heel region of amputated legs by use of a dermatome or a scalpel in a 
similar way as described above for bovine epidermis. Samples were either 
used directly or frozen in liquid nitrogen. Preparation of epidermal tissue 
from various other body locations (e.g., neck, breast, face, arms) have been 
described elsewhere (20,  45-47,  49).  Alternatively, the various layers of 
foot-sole epidermis were prepared by microdissection as described by Moll 
et al. (45, 46). Fetal foot-soles were obtained and processed as described 
previously (45-47,  50). 
Purification of Cytokeratins and Reconstitution 
of  Cytokeratin Complexes  and IF 
To purify bovine cytokeratin No. 9, small pieces of cow heel pad epidermis 
were extracted in 9.5 M urea, 5 mM Tris-HCl (pH 8), 100 mM 2-mercapto- 
ethanol, and processed as described (2, 34). Specifically, the supernatant 
of a 10-min centrifugation at 10,000 g was used to purify cytokeratin No. 9. 
The acidic cytokeratins of bovine heel pad epidermis were collectively 
prepared by  DEAE-cellulose (DE-52;  Whatman Inc.,  Clifton,  NJ)  an- 
ion-exchange chromatography in 8 M urea, 30 mM Tris-HCI (pH 8), 5 mM 
dithiothreitol as described (2, 34).  Cytokeratin No. 9 was then separated 
from epidermal components VI and VII by preparative SDS PAGE as de- 
scribed by Hatzfeld and Franke (34). Other bovine cytokeratins, including 
No. 8 from cytoskeletal material extracted from bladder urothelium (43, 56, 
57), were prepared by ion-exchange chromatography on DEAE-cellulose 
and reverse-phase high performance liquid chromatography (2, 34). 
The preparations of human cytokeratin polypeptides, including No. 9, 
have been described and purity of these preparations has been documented 
elsewhere (2,  34). 
For analysis of cytokeratin complexes by differential "melting" in urea, 
the total cytoskeletal proteins solubilized in 9.5 M urea (see above) or equi- 
molar amounts of purified cytokeratin polypeptides mixed in 9.5 M urea, 
5 mM Tris-HCl (pH 8), 100 mM 2-mercaptoethanol were used. Formation 
of  complexes was examined at various times after dialysis to 5 mM Tris-HC1 
(pH 8) containing different concentrations of urea (24). The reconstituted 
complexes were analyzed by two-dimensional gel electrophoresis, using 
gels containing the same concentration of urea as the electrophoresis sample 
(24). 
IFs were reconstituted by dialyzing the cytokeratin mixtures from the 
9.5-M urea containing buffer to 50 mM Tris-HCl (pH 7.6),  10 mM 2-mer- 
captoethanol. The reconstituted IFs were negatively stained and examined 
by electron microscopy as described (22, 54). 
Isolation and In Vitro Translation of  RNA 
Total cellular RNA was prepared by the guanidinium-HC1 method as de- 
scribed (38, 43), except that the tissues were homogenized in cold (4°C) 
4 M guanidinium-thiocyanate, 0.1 M Tris-HCl (pH 7.5), 0.2% 2-mercapto- 
ethanol, 5 mM EDTA (10 ml/g tissue). 
1-5 }xg of total RNA were translated in vitro using a commercially avail- 
able reticulocyte iysate system with L-[aSSlmethionine as radioactive amino 
acid (1,400 Ci/mmol, Amersham Buchler GmBH, Braunschweig, FRG) as 
described (36, 43). 
Peptide Map Analysis 
Polypeptide spots separated by two-dimensional gel electrophoresis were 
excised from the gel, radioiodinated, digested with trypsin, and analyzed 
according to Elder et al.  (16) using some modifications described (57). 
Gel Electrophoresis and Immunoblot Analysis 
Polypeptides were separated by one- and two-dimensional gel electrophore- 
sis (for methods see 2,  20,  45,  46,  56,  57).  Transfer of polypeptides to 
nitrocellulose paper, reaction with guinea pig antibodies to cytokeratins, in- 
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peptides (17-21, 26, 46, 56), and identification of the antibodies bound by 
[1251J-protein A were performed as described (31). 
Antibodies to Cytokeratin No. 9 and 
lmmunofluorescence Microscopy 
Antisera to purified cytokeratin No. 9 raised in guinea pigs (17), and anti- 
bodies were immunoaflinity purified on cytokeratin No. 9 bound to nitrocel- 
lulose strips, using, however, Ponceau-S instead of Amido black staining, 
and 3 M KSCN for elution (39). Possible traces of residual cross-reactivity 
with other epidermal cytokeratins were removed by additional immunoab- 
sorption on keratins from dissected middle and lower layers of bovine snout 
epidermis which were separated by SDS PAGE and blotted on nitrocellulose 
paper.  For  comparison,  monoclonal  murine  antibody  KG  8.13, which 
shows broad  cytokeratin  specificity (31) was used.  Indirect single- and 
double-label immunofluorescence microscopy was performed on cryostat 
sections essentially as described (50).  The secondary antibodies, fluores- 
cein isothiocyana~-coupled goat antibodies to guinea pig or mouse Ig's and 
Texas Red-labeled goat antibodies to routine Ig's were obtained from Di- 
anova (Hamburg, FRG). 
Results 
Identification of  Bovine Cytokeratin No. 9 
as Translation Product 
To examine whether bovine cytokeratin polypeptide No. 9 is 
a genuine product of translation of a tissue-specific mRNA, 
we isolated RNA from the total epidermis of the heel pad 
above the hoof (for histology see 41, 69) and used it for trans- 
lation in vitro in the rabbit reticulocyte lysate system. For 
comparison, RNA samples isolated from epidermis of other 
body sites such as muzzle and normal hair follicle-contain- 
ing skin of the cheek region were used in parallel. As an ex- 
ample, Fig. 1, a-c, presents the major cytokeratin polypep- 
tides of bovine muzzle epidermis and the corresponding in 
vitro translation products, identified by co-electrophoresis. 
Cytokeratins designated Ia-c,  III,  IV,  VIa,b  and VII ap- 
peared as the prominent polypeptides of both the tissue (a,b) 
and  in  vitro  translation  (c).  In  addition,  we consistently 
noted two minor basic  (type II) cytokeratin polypeptides, 
designated No. 4 and 5 in previous reports (36, 38; see also 
20).  Most of the mRNAs encoding these components have 
recently been cloned, partially sequenced, and identified as 
distinct gene products (35-37,  42).  The same components 
have also been identified among the in vitro translation prod- 
ucts of other regions of the cow's head and rump which con- 
rained the hair follicle ct-keratins as additional components 
(these authors, unpublished findings). 
The heel pad epidermis displayed a  different pattern of 
cytokeratins and of translational products in vitro (Fig.  1, 
d-f). In this tissue, polypeptides corresponding in size and 
electrical charge to cytokeratins Ia-c (Nos. 1-3 of the bovine 
catalog  of reference  57)  were  not  detected.  Instead,  the 
cytokeratin polypeptide No. 5 appeared as a major cytokera- 
tin, and the proportion of polypeptide No. 4 was greater than 
in the epidermal samples from other body locations. The rel- 
ative amounts of epidermal keratins III and IV were also 
higher. The most remarkable difference, however, was found 
in the complement of acidic (type I) cytokeratins which com- 
prised, besides keratins VIa,b and VII, a third major poly- 
peptide of Mr 64,000.  This cytokeratin (No.  9)  was often 
resolved into a series of at least three isoelectric variants in 
isoelectric focusing (Fig. 1 e), probably representing differ- 
ent degrees of phosphorylation, and seemed to correspond 
to the upper intense band in the range of Mr 60,000-64,000 
described in previous one-dimensional gel electrophoretic 
separations reported by us and other authors studying bovine 
hoof epidermis (14, 17, 41, 63).  In addition, we frequently 
noted in such cytoskeletal preparations a minor acidic poly- 
peptide of an isoelectric point similar to that of cytokeratin 
VII but slightly faster in electrophoresis in the presence of 
SDS (arrows in Fig. 1, d and  f). Probably this latter polypep- 
tide, whose cytokeratinous nature is not fully clear, corre- 
sponds to the Mr 48,000  component designated epidermal 
keratin band VIII in our previous one-dimensional analyses 
(17, 26). Clearly and most importantly, the in vitro transla- 
tion of bovine sole epidermal RNA (Fig. 1 f) provided evi- 
dence that both acidic components, cytokeratin No. 9 and 
the small Mr 48,000  polypeptide, are products of distinct 
RNAs. 
These findings are  schematically summarized in Fig.  2 
which shows the common bovine epidermal keratins and the 
body site-specific ones. 
Criteria for Classification  of  Bovine Epidermal 
Polypeptide No. 9 as a Cytokeratin 
Epidermal polypeptide No. 9 has previously been classified 
as a cytokeratin because of its resistance to extractions with 
low and high salt buffers and various detergents, its solubility 
in high concentrations of urea and citric acid, its inclusion- 
among several other keratins-in reconstituted IFs produced 
from total hoof-sole epidermis, and its cross-reactivity with 
several  guinea pig  antisera raised  against bovine muzzle 
epidermal cytokeratins (e.g., 17, 18, 26; see also 14, 41, 63). 
On the other hand, it does not significantly react with sub- 
family I-specific monoclonal antibodies such as AE1  (cf. 
68). In the present study we have used additional and more 
stringent criteria to examine the cytokeratinous nature of this 
polypeptide. In Fig. 3, we show the progressive "melting" of 
cytokeratin complexes in increasing concentrations of urea 
(24).  When bovine heel pad cytokeratins were denatured in 
buffer containing 9.5 M urea and then dialyzed against vari- 
ous concentrations of urea, polypeptide No.  9 was seen at 
5 M and 6 M urea (Fig. 3, a and b) in the same intermediate 
isoelectric position as the other cytokeratins present, indica- 
tive of its inclusion in a typical cytokeratin complex. At con- 
centrations of 7 M and above, polypeptide No. 9 separated 
from the other cytokeratins and migrated to its typical posi- 
tion at pH '~5.4 (Fig. 3, c-e). This melting behavior is typi- 
cal of  cytokeratin complexes of  an intermediate melting point 
(Urn) between 6 and 7 M urea (24, 25, 34).  A similar com- 
plex  formation and melting behavior was  observed when 
purified polypeptide No. 9 was mixed with bovine epidermal 
keratins III and IV and the non-epidermal cytokeratin No. 8 
(not shown). 
We also examined the ability of purified bovine cytokeratin 
No. 9 to form IFs in vitro by mixing it, in a molar ratio of 
'~1:1, with various basic (type II) cytokeratins such as epider- 
mal components III and IV and the non-epidermal cytokera- 
tin No.  8 isolated from bovine bladder. All these combina- 
tions resulted in the formation of typical protofilaments and 
IFs as judged from electron microscopy. As an example we 
show in Fig. 4, the IFs formed in vitro from the combination 
of cytokeratins 8 and 9, which are not co-expressed in any 
Knapp et al. Cytokeratin  No.  9  659 Figure 1. Two-dimensional gel electrophoresis of cytokeratins isolated from bovine muzzle and heel pad epidermis and the in vitro transla- 
tion products of mRNA extracted from these tissues. Non-equilibrium pH gradient (NEPHG; a-d and f) electrophoresis or isoelectric 
focusing (IEF; e) was used in the first dimension. SDS, direction of the electrophomsis in the second dimension, in the presence of SDS. 
(a) Coomassie Blue staining of a gel showing all cytokeratins  of  bovine muzzle epidermis, with basic components Ia-c and I~/IV particularly 
well resolved. Note cytokeratin Nos. 4 and 5 as minor components. (b and c) Co-electrophoresis of muzzle epidermis keratins and the 
in vitro translation products of muzzle epidermal mRNA: (b) Coomassie Blue staining; (c) fluorograph of the same gel, showing the 
[3SS]methionine-labeled  proteins synthesized in  vitro.  (d)  Coomassie Blue  staining of cytokeratins extracted from bovine heel  pad 
epidermis. Note considerable amounts of cytokeratin Nos. 4, 5, and 9. (e) Same preparation as in d but using IEF in the first dimension 
to resolve the isoelectric variants of the acidic cytokeratin polypeptides, notably No. 9. (f) Fluorograph of the same gel as shown in d, 
presenting the co-electrophoresed [35S]methionine-labeled  in vitro translation products of mRNA extracted from heel pad epidermis. Note 
that component Nos. 4,  5, and 9 are among the major translation products. 
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of polypeptide No. 9. 
Identification of  Human Cytokeratin No. 9 
as a Translation  Product 
We also compared the cytokeratins of human epidermis from 
various body sites (e.g., breast, face), including tumors and 
fetal epidermis (20, 45-50) with those present in epidermis 
of foot soles and palms. The typical complement of cytokera- 
tins characteristic of normal human interfollicular epidermis 
has been amply documented in the literature, including anal- 
yses of products of in vitro translation of epidermal RNA 
(e.g., 3, 7-9,  11, 15, 20, 27-30,  32, 45, 46, 49, 65-67).  The 
data obtained in the course of the present study confirm the 
literature data, notably those of Fuchs and Green (27, 28; see 
also 32).  Therefore, in this paper we present only the data 
referring to human foot-sole epidermis. Cytoskeletal prepa- 
rations from epidermal tissue obtained from amputated feet 
or legs  contain,  with  somewhat variable  frequencies and 
degrees of preservation, a relatively large amount of a rather 
acidic (isoelectric in 9.5 M  urea at pH 5.4) polypeptide of 
approximately Mr 64,000 designated cytokeratin No. 9 (Fig. 
5, a and b; cf. 45-47). Criteria for its keratinous nature have 
been given in previous papers,  including the ability of the 
polypeptide  purified  by  anion-exchange  chromatography 
and subsequent reverse-phase high performance liquid chro- 
matography to form complexes and IFs with various purified 
epidermal and non-epidermal type II cytokeratin polypep- 
tides (34, 45, 46). 
Fig. 5, c and d, shows the [35S]methionine-labeled  prod- 
ucts of in vitro translation of mRNA isolated from human 
foot sole epidermis. Cytokeratin polypeptides Nos.  1, 5, 6, 
9,  I0/11, 14, and 16 are clearly identified among the major 
mRNA products of this tissue, which include considerable 
amounts of actin. This demonstrates that cytokeratin No. 9 
is a genuine epidermal polypeptide which, however,  is de- 
tectable with this method only in specific body sites such as 
plantar epidermis. Moreover, the lack of  translation products 
of a similar size and electrical charge as cytokeratin No. 9 
in analyses of epidermal RNAs from various other parts of 
the body (data not shown; see also refs. 27, 28, 32) indicates 
that translatable mRNA coding for this protein is not synthe- 
sized in appreciable amounts in epidermis of these regions. 
Similarities and Differences  of  Human and 
Bovine Cytokeratin No. 9 
Although the cytokeratin polypeptides designated No.  9 in 
both the bovine (57) and human (45) catalog exhibit several 
similarities such as in size, isoelectric pH,  and the selec- 
tively  abundant  expression  in  keratinocytes  of  plantar 
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Figure 2. Diagram of bovine cytokeratin  polypeptides (for number- 
ing see reference 57) arranged according to their isoelectric pH 
values and apparent molecular weights (MT X 10  -3) as they appear 
on two-dimensional gel electrophoresis. Cytokeratin components 
only found in bovine muzzle epidermis are indicated by filled cir- 
cles. Open circles denote components which are only detected in 
heel pad epidermis. Polypeptides  found in both tissues are indicated 
by the combination of the two symbols. The cytokeratinous nature 
of the trace component No. 10 of the bovine catalog (57), denoted 
by an open circle with vertical bars, is not yet clear. Filled triangles 
denote reference polypeptides: Bovine serum albumin (B), vimen- 
tin (V), phosphoglycerokinase  (P), and ¢t-actin (,4). X denotes the 
minor component of Mr 48,000 (No. 19 of reference 57). 
specific two-dimensional peptide maps (Fig.  6,  a  and b). 
Clearly, the peptide maps of both polypeptides exclude a ba- 
sic (type U) cytokeratin character (cf. 45, 57). On the other 
hand, this species difference in peptide maps, which has also 
been noted for other acidic (type I) cytokeratins (46, 57) sug- 
gests considerable number of  exchanges in the amino acid se- 
quences of the two polypeptides, a prediction that is cur- 
rently under investigation in our laboratory using cDNA 
clones. 
When guinea pig antibodies raised against purified cyto- 
keratin No. 9 from bovine hoof  pad is examined by immuno- 
blotting analysis, specific reactivity with only cytokeratin 
No.  9 is noted in both species, bovine and human (Fig. 7, 
a'-c'). As human palmar cytokeratin No. 9 is a widespread 
laboratory contaminant, which can present special problems 
in immunoblot studies when very sensitive antibodies react- 
ing with this and/or other cytokeratins are used (for details 
see references 1, 52), we have also confirmed the nature of 
the specific Coomassie Blue-stained antigens as bovine and 
human cytokeratin No.  9  by their species-specific peptide 
map  pattern  (data  not  shown).  The  cross-reactivity  of 
Arabic and Roman numerals denote the different bovine epidermal keratin polypeptides (cf. reference 57). Bovine serum albumin (B), 
phosphoglycerokinase  (P), and ct-actin (A) were added for co-electrophoresis as reference polypeptides. A (1~, Y) denotes the position of 
the labeled bovine 13 and ~/actin, synthesized in vitro from the mRNAs used in these experiments. The arrows in d andfpoint to a bovine 
polypeptide of Mr 48,000 which is a minor component, probably a cytokeratin, of the heel pad epidermis cytoskeleton (previously de- 
scribed as component VIH in references 17 and 26). The triangle in e denotes a trace component in heel pad epidermis which may represent 
a minor specific cytokeratin (No. 10 of the bovine catalog of reference 57). The arrowheads show residual complexes of certain basic and 
acidic cytokeratins  which resist the highly denaturing conditions (9.5 M urea) used to dissociate and denature the proteins before electropho- 
resis (cf. reference 24). Note that cytokeratin No. 9 is detected only in the heel pad epidermis and is a genuine in vitro translation product. 
Knapp  et al. Cytokeratin No.  9  661 Figure 4. Electron micrograph showing a negatively stained prepa- 
ration of IFs re-assembled from purified bovine cytokeratins No. 8 
from bladder and No. 9 from heel pad epidermis. Purified polypep- 
tides were mixed in 9.5 M urea and dialyzed to 50 mM Tris-HC1 
buffer (for details see text).  Typical compact IFs as well as loosely 
packed protofilamentous structures are seen.  Bar,  0.2  ktm. 
Figure 3. Two-dimensional gel electrophoreses of complexes of bo- 
vine cytokeratins from heel pad epidermis, using non-equilibrium 
pH gradient electrophoresis in the first dimension (NE). Downward 
arrow denotes direction of electrophoresis in the second dimension 
in the presence of SDS.  Proteins were dissolved in 9.5 M urea and 
dialyzed against different urea concentrations  as indicated at the 
bottom of  the right comer of the specific figure. Co-electrophoresed 
reference proteins and designations of cytokemtins are as in previ- 
ous figures.  The arrows denote the minor component of Mr 48,000 
(No.  19 of reference 57).  (a) At 5 M  urea all  polypeptides form 
cytokeratin No,  9  in the two species has also been demon- 
strated by immunofluorescence microscopy which displayed 
strong reaction on keratinocytes of bovine hoof pad (Fig.  7, 
d-f)  as well as human  foot-sole. 
lmmunolocalization of Cytokeratin No. 9 
When antibodies  specifically recognizing cytokeratin No.  9 
were  used  for immunofluorescence  microscopy  on  bovine 
hoof pad epidermis, intense staining was seen in columns of 
suprabasal keratinocytes (Fig.  7, d  and e). The first signs of 
cytokeratin  No.  9  positivity  were  usually  apparent  in  the 
fourth or fifth cell layer.  In upper layers of this  epidermis, 
most keratinocytes  were  strongly  stained  although  still  in- 
dividual cells were noted that were negative for cytokeratin 
No. 9 but positive for other cytokeratins (Fig. 7f).  Columns 
of cytokeratin  No.  9-positive cells  were also prominent  in 
human foot-soles reacted with the antibodies against bovine 
cytokeratin No.  9  (data not  shown). 
Unexpectedly,  we  found  that  keratinocytes  expressing 
cytokeratin No.  9  were not restricted to plantar and palmar 
epidermis. Immunofluorescence microscopy of cryostat sec- 
tions  of skin  from various  body sites  showed  sparse cyto- 
keratin  No.  9-positive  ceils  also  in  other  locations  where 
they occurred as individual cells or piles of ceils.  As an ex- 
ample, double label immunofluorescence microscopy of bo- 
vine snout epidermis is presented in Fig.  8, a  and b. While 
"broad  spectrum"  cytokeratin  antibodies  such  as  KG  8.13 
stain all keratinocytes of all layers (Fig. 8 a) the few cytokera- 
tin  No.  9-positive  cells  are  restricted  to  certain  regions 
where they often form clustered or columnar arrays (Fig.  8 
b).  In addition,  cytokeratin No.  9-positive cells  were seen 
around  certain  glandular  ducts  present  in  this  tissue.  The 
presence of cytokeratin No. 9 in some cells of the uppermost 
layers was confirmed by immunobtotting ofcytoskeletal pro- 
teins of such tissue regions microdissected from cryostat sec- 
tions  (not shown;  for technique  see reference 50). 
Sparsely  distributed  piles  of cytokeratin  No.  9-positive 
cells were also found in some non-palmar,  non-plantar hu- 
complexes which are still stable at 6 M urea (b). (c) At 7 M urea, 
cytokeratin No. 9 as well as the basic cytokemtins 5, HI, IV and 
the acidic cytokeratin VII have partially separated from the complex 
position (arrowhead). (d) At 7.5 M urea further dissociation of the 
complexes is seen and at 9.5  M  urea (e) separation is complete. 
The Journal of Cell Biology, Volume 103, 1986  662 Figure 5. Two-dimensional gel electrophoresis of cytoskeletal pro- 
teins isolated from human foot-sole epidermis and the in vitro trans- 
lation products  of mRNA extracts  from this tissue,  using non- 
equilibrium pH gradient (NEPHG; a, c, and d) electrophoresis or 
isoelectric focusing (IF.F; b) in the first dimension. Arabic numer- 
Figure 6. Comparison of  tryptic peptide maps of bovine and human 
cytokeratin No.  9  (E,  electrophoresis;  C,  chromatography).  (a) 
Component No. 9 from heel pad epidermis; (b) component No. 9 
from foot-sole epidermis. Note remarkable differences of the two 
patterns. 
man body sites such as the neck epidermis (not shown). A 
detailed dermatological study on the histological and ana- 
tomical distribution of these cytokeratin No.  9-expressing 
keratinocytes  will  be  presented  elsewhere  (Moll,  I.,  H. 
Heid, T. Achtst/itter,  N. Zaidi, W. W. Franke, and R. Moll, 
manuscript in preparation). 
Discussion 
The results of this study confirm the existence of an acidic 
polypeptide  of  Mr  64,000  with  cytokeratinous  features 
which occurs as an abundant protein in the epidermis of hu- 
man foot-soles and palms as well as in the bovine equivalent 
(i.e., the heel pad of  the hoof), but so far had not been found 
in epidermal tissue of other body sites (cf. 7, 14, 17, 28, 32, 
41, 45, 46, 49, 63). Our demonstration that in both species 
this polypeptide is a major in vitro translation product pro- 
vides definitive evidence that it is an intact, genuine cytoker- 
atin encoded by a specific mRNA. The development of anti- 
bodies specific for cytokeratin No. 9 has now also allowed 
the identification of sparse cells expressing this protein in the 
epidermis of other (i.e., non-palmar, non-plantar) body sites 
which have escaped detection by the relatively crude integral 
biochemical methods used previously. 
We conclude, in agreement with data of other authors (7, 
28, 32), that cytokeratin No. 9 is expressed during terminal 
differentiation of a certain subtype of keratinocytes which is 
very rare at most body sites but is abundantly present in plan- 
tar and palmar epidermis. From our findings that cytokeratin 
No. 9 is present in calf fetuses and in relatively early stages 
of human fetal development (for a demonstration in 20-wk 
fetuses see reference 50), we also conclude that cytokeratin 
No. 9 is not a "stress protein" induced by external influence 
in palms and soles and suggest that its enhanced expression 
in these tissues is related to the morphogenesis of these parts 
of the body. 
als denote the human cytokeratin polypeptides according to Moll 
et al. (45). Other symbols are as in Fig. 1. (a) Coomassie Blue stain- 
ing of a gel showing the major cytokeratins of microdissected foot- 
sole epidermis; arrowheads denote residual amounts of  the very sta- 
ble complex of cytokeratin Nos. 5 and  14 (cf. reference 34).  (b) 
Coomassie Blue staining of the acidic cytokeratins separated by 
isoelectric focusing, resolving the individual isoelectric variants. 
(c) Fluorograph showing the major in vitro translation products of 
total RNA from foot sole epidermis as revealed after short exposure 
(1.5 d). (d) Longer (8 d) exposure fluorograph of the gel shown in 
c, revealing significant amounts ofpolypeptide Nos. 1, 9, and 10/ll. 
Knapp et al. Cytokeratin  No. 9  663 Figure Z Characterization of affinity-purified  guinea-pig antibodies against bovine cytokeratin  No. 9 by immunoblotting and immunofluores- 
cence microscopy. (a-c') Gel electrophoresis and immunoblotting of cytoskeletal polypeptides from various tissues and culture cells. (a) 
SDS PAGE showing major cytokeratins Coomassie Blue staining. (Lane 1 ) Proteins from middle and lower layers of bovine snout epidermis; 
(lane 2) proteins from human foot-sole; (lane 3) bovine heel pad epidermis; (lane 4) proteins from cultured human mammary adenocarci- 
noma ceils of line MCF-7 (for details see reference 45). (a') Autoradiography of~aitrocellulose paper blot of an SDS PAGE in parallel to 
that shown in a  after reaction with antibodies against cytokeratin No. 9,  followed by incubation with ~25I-labeled  protein A. Significant 
immunoreaction is seen only with a polypeptide of Mr •64,000,  i.e. cytokeratin No. 9, in human foot-sole (lane 2') as well as bovine heel 
pad (lane 3'). In contrast, cytokeratins of middle and lower layers of bovine snout epidermis (lane 1') and MCF-7 cells (lane 4') are negative. 
(b and b') Two-dimensional gel electrophoresis (symbols as in Fig. 1; in this example an extended pH range of ampholytes was used; cf. 
The Journal of Cell Biology,  Volume 103, 1986  664 Figure 8.  Double-label immunofluorescence microscopy of a frozen section through bovine snout epidermis with monoclonal murine anti- 
body K~ 8.13 (a) and affinity-purified pig guinea antibodies against cytokeratin No. 9 (b). While the broad range monoclonal cytokeratin 
antibody reacts with keratinocytes of all layers of snout epidermis,  only individual cells or small clusters of cells located in upper layers 
of  epidermis reveal positive staining for cytokeratin No. 9 (some keratinocytes that are positive with both antibodies are indicated by arrows). 
CZ, connective tissue.  Bar, 100 lam. 
Our results allow us to define at least two different types 
of keratinocytes distinguishable by their patterns of terminal 
differentiation,  one type that synthesizes cytokeratin No.  9 
and one type that does not. At present it is not clear whether 
the cytokeratin No. 9-positive keratinocytes also express the 
other large type I cytokeratin(s) characteristic of suprabasal 
differentiation (i.e., cytokeratin Nos.  10 and 11 [cf. 2, 9, 28, 
32,  45,  66,  67]),  or whether the expression of cytokeratin 
No. 9, on the one hand, and Nos. 10/11, on the other, is mutu- 
ally exclusive. The reason for the selectively high frequency 
of the cytokeratin No. 9-expressing type of keratinocytes in 
certain regions of epidermis but not in others is not known. 
It will be exciting to identify the factors that induce the ex- 
pression of this protein so specifically in one subtype of ker- 
atinocytes.  We also cannot say at the moment whether the 
specific synthesis of cytokeratin No. 9 is also related to spe- 
cial  functions  of this  protein  in  the  keratinocytes  of the 
callus-forming epidermis of the palms and the sole and/or 
contributes to the formation of special morphological fea- 
tures of this epidermis such as ridges and sulci (for histology 
see 41, 50, 51, 69). In this context, a close spatial relationship 
to the terminal ("straight") portions of sweat gland ducts of 
human foot-soles is striking. 
At present we also do not know whether the expression of 
the anatomical site-specific cytokeratin No. 9 is maintained 
in keratinocytes growing in culture and whether its synthesis 
is influenced by vitamin A and its analogs as it has been de- 
scribed for other epidermal cytokeratins (29, 32). It will also 
be  important  to  find  out  whether  the  expression  of this 
cytokeratin is switched off after grafting of palmar or plantar 
keratinocytes to other regions  of the  body and  whether it 
represents an intrinsic or an extrinsic program of regulation 
(for discussion see reference  13). 
The observations of this study as well as those of previous 
reference 57) of cytoskeletal polypeptides from bovine heel pad. (b) Coomassie blue-stained  gel; (b') corresponding immunoblot reaction 
on nitrocellulose paper. Positive immunoreaction  is detected only with cytokeratin No. 9 (c and c') Two-dimensional gel electrophoresis 
of cytoskeletal polypeptides of human foot-sole (conditions as in b). (c) Coomassie Blue staining (arrows denote yet unidentified stratum 
corneum  polypeptides;  cf.  reference 49);  (c') corresponding  immunoblot  reaction  with  antibodies  to cytokeratin  No.  9,  showing the 
specificity for this cytokeratin. (d-f) Immunofluorescence microscopy of cryostat sections of bovine heel pad epidermis, using broad range 
monoclonal murine antibody KG 8.13 (d) and affinity-purified pig guinea antibodies against cytokeratin No. 9 (e and f). All epidermal 
cells are positive with antibody KG 8.13 (d), whereas the antibodies to cytokeratin No. 9 do not show significant reaction with the basal 
cell layer and the first suprabasal cell layers (demarcated by brackets in e) and react only with certain columns and clusters of cells of 
suprabasal layers. The frequency of cytokeratin No. 9-positive cells increases in upper layers (fshows a region near the apical surface). 
Note, however, that even in these upper layers not all cells are positively stained.  CT, connective tissue. Bars,  100 ~tm. 
Knapp et al. Cytokeratin No.  9  665 papers (14, 17, 41, 63) further indicate that there are some 
other site-specifically  expressed epidermal cytokeratin poly- 
peptides,  at least in the bovine heel pad,  such as the Mr 
48,000  component designated  VIII (No.  19 of the bovine 
catalog  of reference  57).  The phenomenon of anatomical 
site-determined  expression of certain cytokeratins may also 
not be restricted to higher mammals and feet and hands. Can- 
didates for such a body site-specific synthesis have been de- 
scribed,  for example,  for the epidermis of mouse tails and 
ears (59). 
Our results, taken together with those of a preceding study. 
(34), indicate that the human acidic (type I) cytokeratin No. 
9  of M, 64,000  forms complexes with the basic  (type II) 
cytokeratin No.  1 (Mr 68,000) and No.  2  (Mr 65,500) and 
probably also No. 5 (Mr 58,000), and that bovine cytokera- 
tin No. 9 forms complexes with bovine cytokeratins No. 4 
(Mr 59,000), No. 5 (Mr 58,000) and No. 6 (i.e.,  epidermal 
component III; Mr 56,000). This demonstrates  that the size 
difference  of Mr •8,000  observed between the specific  ba- 
sic  and  acidic  cytokeratin  polypeptide  partners  of most 
"pairs" (9, 64, 67) is not a necessary requirement of cytokera- 
tin complex and IF formation. 
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